Delivery Order SPE2DR25D3103-SPE2DR26F9V10
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $38,387.34 for Lidocaine 5% patches (30-count units) by the Defense Logistics Agency on December 31, 2025. The contract is non-competitive and structured as a firm fixed-price delivery order with an ultimate completion date of January 2, 2026. This award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 19, 2025, for the supply of Lidocaine 5% Patch 30s with a ceiling value of $5,131.45. This is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and was competitively awarded without any set-aside designation. The award falls under AmerisourceBergen's existing Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order by the Defense Logistics Agency for Lidocaine 5% Patch 30s on July 8, 2025. The delivery order, valued at $4,520.16, represents a competitive award with no set-aside designation and an ultimate completion date of July 9, 2025. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on December 4, 2025, for Lidocaine 5% Patch 30s with a ceiling value of $6,016.01. The contract is a firm fixed-price delivery order with an ultimate completion date of December 5, 2025, and carries no set-aside designation. This award represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order by the Defense Logistics Agency on September 5, 2025, for the supply of Lidocaine 5% Patch 30-count units. This firm fixed-price contract carries a ceiling value of $8,709.12 and is scheduled for completion by September 8, 2025. The award was made without a set-aside designation, indicating it was competed among qualified vendors in the open...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on November 10, 2025, by the Defense Logistics Agency for Lidocaine 5% Patch 30s under a firm fixed-price contract arrangement. The order, valued at $7,358.52, is scheduled for completion by November 12, 2025, with performance taking place at the awardee's Conshohocken facility. This delivery order represents a competitive award with no set-aside designation...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30-count units under a firm fixed-price contract with a ceiling value of $4,246.98. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of July 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain for the supply of Lidocaine 5% Patch 30s, valued at $14,810.39. This competitively awarded, non-set-aside contract carries a firm fixed price arrangement with an ultimate completion date of July 28, 2025. The product will be delivered to the awardee's facility in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $23,630.40. The award, issued on May 7, 2025, is a competitive contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location. This contract represents a child order under the company's larger...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for Lidocaine 5% Patch 30s with a ceiling value of $2,305.31. The contract was awarded on January 5, 2026, with an ultimate completion date of January 6, 2026, and utilizes firm fixed price pricing. The award is unset-aside and competitively awarded, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9V10Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for $7.62 thousand to supply Lidocaine 5% Patch 30s, with an ultimate completion date of January 7, 2026. The contract utilizes a firm fixed-price structure and was competitively awarded without a set-aside designation. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.99 million through December 2031, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. The Lidocaine patch delivery supports the Defense Health Agency and other federal healthcare systems' pain management capabilities. AmerisourceBergen's pharmaceutical distribution portfolio demonstrates extensive federal contracting experience, providing a diverse range of medications and medical supplies across multiple therapeutic domains to military treatment facilities and veterans' healthcare programs. The non-set-aside competitive award reflects the contractor's established capability to meet federal procurement requirements for essential pharmaceutical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 1/5/26 |